Ganlu Deng

988 total citations
25 papers, 785 citations indexed

About

Ganlu Deng is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Ganlu Deng has authored 25 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Ganlu Deng's work include Cancer Cells and Metastasis (8 papers), TGF-β signaling in diseases (4 papers) and Ferroptosis and cancer prognosis (4 papers). Ganlu Deng is often cited by papers focused on Cancer Cells and Metastasis (8 papers), TGF-β signaling in diseases (4 papers) and Ferroptosis and cancer prognosis (4 papers). Ganlu Deng collaborates with scholars based in China, United States and Canada. Ganlu Deng's co-authors include Shan Zeng, Cao Guo, Hong Shen, Changjing Cai, Ying Han, Ling Yin, Yiyi Li, Junli Ma, Yan Zhang and Yaojie Fu and has published in prestigious journals such as Scientific Reports, Journal of Cell Science and Journal of Cellular Physiology.

In The Last Decade

Ganlu Deng

24 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ganlu Deng China 15 451 254 235 131 101 25 785
Peiguo Cao China 18 581 1.3× 496 2.0× 168 0.7× 130 1.0× 90 0.9× 58 878
Xiaohu Zhou China 20 542 1.2× 317 1.2× 263 1.1× 145 1.1× 154 1.5× 41 983
Qingyang Gu China 13 350 0.8× 151 0.6× 235 1.0× 114 0.9× 62 0.6× 26 666
Yongfu Xiong China 19 516 1.1× 312 1.2× 254 1.1× 211 1.6× 76 0.8× 56 1.0k
Liuxin Cai China 10 381 0.8× 205 0.8× 208 0.9× 157 1.2× 55 0.5× 18 712
Vijesh Kumar Yadav Taiwan 18 502 1.1× 310 1.2× 173 0.7× 147 1.1× 61 0.6× 41 814
Zhe Su China 16 307 0.7× 343 1.4× 314 1.3× 169 1.3× 66 0.7× 42 857
Shi Zuo China 14 484 1.1× 221 0.9× 142 0.6× 98 0.7× 182 1.8× 52 837
Hao Zhuang China 21 770 1.7× 460 1.8× 180 0.8× 118 0.9× 73 0.7× 60 1.1k

Countries citing papers authored by Ganlu Deng

Since Specialization
Citations

This map shows the geographic impact of Ganlu Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ganlu Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ganlu Deng more than expected).

Fields of papers citing papers by Ganlu Deng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ganlu Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ganlu Deng. The network helps show where Ganlu Deng may publish in the future.

Co-authorship network of co-authors of Ganlu Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Ganlu Deng. A scholar is included among the top collaborators of Ganlu Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ganlu Deng. Ganlu Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Deng, Ganlu, et al.. (2024). The Role of Type 2 Diabetes Mellitus–Related Risk Factors and Drugs in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 11. 159–171. 7 indexed citations
3.
Deng, Ganlu, et al.. (2024). Ferroptosis: insight into the treatment of hepatocellular carcinoma. Cancer Cell International. 24(1). 376–376. 7 indexed citations
4.
Huang, Huasheng, Xiwen Liao, Xinping Ye, et al.. (2024). Role of CCR1/5/7 in hepatocellular carcinoma: a study on prognostic evaluation, molecular subtyping, and association with immune infiltration.. PubMed. 16(7). 6229–6261. 4 indexed citations
5.
Qin, Yiming, Xiongbing Zu, Yin Li, et al.. (2023). A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer. iScience. 26(9). 107722–107722. 8 indexed citations
6.
Ma, Yonggang, et al.. (2023). Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma. Frontiers in Pharmacology. 14. 1167418–1167418. 4 indexed citations
7.
Mao, Linfeng, et al.. (2022). Influence of Hashimoto thyroiditis on diagnosis and treatment of thyroid nodules. Frontiers in Endocrinology. 13. 1067390–1067390. 13 indexed citations
8.
Guo, Cao, Ping Liu, Ganlu Deng, et al.. (2021). Honokiol induces ferroptosis in colon cancer cells by regulating GPX4 activity.. PubMed. 11(6). 3039–3054. 58 indexed citations
9.
Deng, Ganlu, Yihong Chen, Cao Guo, et al.. (2020). BMP4 promotes the metastasis of gastric cancer by inducing epithelial–mesenchymal transition via ID1. Journal of Cell Science. 133(11). 23 indexed citations
10.
Chen, Yihong, Ganlu Deng, Yaojie Fu, et al.. (2020). <p>FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer</p>. OncoTargets and Therapy. Volume 13. 1625–1635. 40 indexed citations
11.
Shen, Hong, Ling Yin, Ganlu Deng, et al.. (2018). Knockdown of Beclin‐1 impairs epithelial‐mesenchymal transition of colon cancer cells. Journal of Cellular Biochemistry. 119(8). 7022–7031. 48 indexed citations
12.
Deng, Ganlu, Shan Zeng, Qingqing Luo, et al.. (2018). BMP4 promotes hepatocellular carcinoma proliferation by autophagy activation through JNK1-mediated Bcl-2 phosphorylation. Journal of Experimental & Clinical Cancer Research. 37(1). 156–156. 41 indexed citations
13.
Ma, Junli, Shan Zeng, Yan Zhang, et al.. (2017). BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma. Cancer Letters. 411. 117–129. 67 indexed citations
14.
Zeng, Shan, Yan Zhang, Junli Ma, et al.. (2017). BMP4 promotes metastasis of hepatocellular carcinoma by an induction of epithelial–mesenchymal transition via upregulating ID2. Cancer Letters. 390. 67–76. 35 indexed citations
15.
Deng, Ganlu, Shan Zeng, Junli Ma, et al.. (2017). The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma. Scientific Reports. 7(1). 41616–41616. 64 indexed citations
16.
Guo, Cao, Junli Ma, Ganlu Deng, et al.. (2017). ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells. Journal of Cancer. 8(17). 3555–3566. 41 indexed citations
17.
Shen, Hong, Junli Ma, Ganlu Deng, et al.. (2016). Integrin-linked kinase overexpression promotes epithelial-mesenchymal transitionvianuclear factor-κB signaling in colorectal cancer cells. World Journal of Gastroenterology. 22(15). 3969–3969. 26 indexed citations
18.
Zhang, Yan, Shan Zeng, Junli Ma, et al.. (2016). Nestin overexpression in hepatocellular carcinoma associates with epithelial-mesenchymal transition and chemoresistance. Journal of Experimental & Clinical Cancer Research. 35(1). 111–111. 38 indexed citations
19.
Zhang, Yan, Junli Ma, Sai Zhang, et al.. (2015). A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites. International Journal of Colorectal Disease. 30(9). 1173–1183. 40 indexed citations
20.
Deng, Ganlu. (2015). Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges. World Journal of Hepatology. 7(5). 787–787. 141 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026